Regulation of PXR in drug metabolism: chemical and structural perspectives

被引:2
作者
Gee, Rebecca R. Florke [1 ,2 ]
Huber, Andrew D. [2 ,3 ]
Chen, Taosheng [2 ,3 ]
机构
[1] St Jude Childrens Res Hosp, Grad Sch Biomed Sci, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN USA
[3] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl,Mail Stop 1000, Memphis, TN 38105 USA
关键词
Detoxification; drug-drug interactions; drug metabolism; nuclear receptor; posttranslational modifications; pregnane X receptor; PREGNANE-X-RECEPTOR; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; UGT1A1; GENE-EXPRESSION; PRIMARY CULTURED RAT; ST JOHNS WORT; NUCLEAR RECEPTORS; XENOBIOTIC RECEPTOR; ACTIVATED RECEPTOR; CROSS-TALK;
D O I
10.1080/17425255.2024.2309212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IntroductionPregnane X receptor (PXR) is a master xenobiotic sensor that transcriptionally controls drug metabolism and disposition pathways. PXR activation by pharmaceutical drugs, natural products, environmental toxins, etc. may decrease drug efficacy and increase drug-drug interactions and drug toxicity, indicating a therapeutic value for PXR antagonists. However, PXR's functions in physiological events, such as intestinal inflammation, indicate that PXR activators may be useful in certain disease contexts.Areas coveredWe review the reported roles of PXR in various physiological and pathological processes including drug metabolism, cancer, inflammation, energy metabolism, and endobiotic homeostasis. We then highlight specific cellular and chemical routes that modulate PXR activity and discuss the functional consequences. Databases searched and inclusive dates: PubMed, 1 January 1980 to 10 January 2024Expert opinionKnowledge of PXR's drug metabolism function has helped drug developers produce small molecules without PXR-mediated metabolic liabilities, and further understanding of PXR's cellular functions may offer drug development opportunities in multiple disease settings.
引用
收藏
页码:9 / 23
页数:15
相关论文
共 50 条
  • [41] Transcriptional regulation of human paraoxonase 1 by PXR and GR in human hepatoma cells
    Ponce-Ruiz, N.
    Rojas-Garcia, A. E.
    Barron-Vivanco, B. S.
    Elizondo, G.
    Bernal-Hernandez, Y. Y.
    Mejia-Garcia, A.
    Medina-Diaz, I. M.
    TOXICOLOGY IN VITRO, 2015, 30 (01) : 348 - 354
  • [42] Xenosensors CAR and PXR at Work: Impact on Statin Metabolism
    Marino, Maria
    Di Masi, Alessandra
    Trezza, Viviana
    Pallottini, Valentina
    Polticelli, Fabio
    Ascenzi, Paolo
    CURRENT DRUG METABOLISM, 2011, 12 (03) : 300 - 311
  • [43] Structural and Functional Analysis of the Human Nuclear Xenobiotic Receptor PXR in Complex with RXRα
    Wallace, Bret D.
    Betts, Laurie
    Talmage, Garrick
    Pollet, Rebecca M.
    Holman, Natalie S.
    Redinbo, Matthew R.
    JOURNAL OF MOLECULAR BIOLOGY, 2013, 425 (14) : 2561 - 2577
  • [44] Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids
    Dvorak, Zdenek
    Pavek, Peotr
    DRUG METABOLISM REVIEWS, 2010, 42 (04) : 621 - 635
  • [45] Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice
    McMillan, JoEllyn M.
    Cobb, Denise A.
    Lin, Zhiyi
    Banoub, Mary G.
    Dagur, Raghubendra S.
    Woods, Amanda A. Branch
    Wang, Weimin
    Makarov, Edward
    Kocher, Ted
    Joshi, Poonam S.
    Quadros, Rolen M.
    Harms, Donald W.
    Cohen, Samuel M.
    Gendelman, Howard E.
    Gurumurthy, Channabasavaiah B.
    Gorantla, Santhi
    Poluektova, Larisa Y.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (02) : 272 - 280
  • [46] Cytochrome P450 Regulation by α-Tocopherol in Pxr-Null and PXR-Humanized Mice
    Johnson, Caroline H.
    Bonzo, Jessica A.
    Cheng, Jie
    Krausz, Kristopher W.
    Kang, Dong Wook
    Luecke, Hans
    Idle, Jeffrey R.
    Gonzalez, Frank J.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (02) : 406 - 413
  • [47] Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice
    Park, Young Joo
    Lee, Eun Kyung
    Lee, Yoon Kwang
    Park, Do Joon
    Jang, Hak Chul
    Moore, David D.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 263 (02) : 131 - 137
  • [48] Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics
    de Jong, Laura M.
    Jiskoot, Wim
    Swen, Jesse J.
    Manson, Martijn L.
    GENES, 2020, 11 (12) : 1 - 24
  • [49] The 3′-untranslated region contributes to the pregnane X receptor (PXR) expression down-regulation by PXR ligands and up-regulation by glucocorticoids
    Smutny, Tomas
    Dusek, Jan
    Hyrsova, Lucie
    Nekvindova, Jana
    Horvatova, Alzbeta
    Micuda, Stanislav
    Gerbal-Chaloin, Sabine
    Pavek, Petr
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (01) : 136 - 152
  • [50] Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters
    Ghose, Romi
    Omoluabi, Ozozoma
    Gandhi, Adarsh
    Shah, Pranav
    Strohacker, Kelley
    Carpenter, Katie C.
    McFarlin, Brian
    Guo, Tao
    LIFE SCIENCES, 2011, 89 (1-2) : 57 - 64